Commentary Recommendation of α1-adrenoceptor antagonist dose increase therapy (DIT) for men with lower urinary tract symptoms associated with benign prostatic hyperplasia Author(s): Masaki Watanabe*, Satoshi Yamaguchi, Hidehiro Kakizaki and Hironori Ishida DOI: 10.14534/j-pucr.2022.285
HTML PDF